The Division of Addiction Science, Prevention, and Treatment is comprised of three strong & inter-related components: Clinical/Treatment, Research, and Education/Training. The Division provides a distinctive environment for conducting addiction research and for training students, postdoctoral fellows and junior faculty. The strong relationship between the Division's research and clinical programs facilitates & accelerates the pace at which research is translated into clinical practice. Current Division addiction research programs and expertise include genetics, epidemiology, biomarkers of addiction and treatment response, medication development, human laboratory studies, clinical trials, implementation research, deep brain stimulation, health and neurocognitive effects of cannabis use across the lifespan.
The Division is home to the Rocky Mountain Cannabis Research Center (RM-CRC) offering mentored research training and pilot research funding opportunities for medical students, graduate students, post-doctoral fellows, and junior faculty interested in cannabis research. The RM-CRC places special emphasis on recruitment and outreach to trainees and junior faculty from groups underrepresented in medicine.
About Our Division Chair
The Division of Addiction Science, Prevention, and Treatment is the largest research-focused Division in the Department of Psychiatry with 9 research faculty with 15 federally-funded grant awards among them including the NIDA-funded Rocky Mountain Cannabis Research Center (RM-CRC) The Division also provides an unparalleled addiction research training and mentorship environment for medical students, residents, post-doctoral fellows, and junior faculty. The RM-CRC places special emphasis on providing mentored research and pilot research funding opportunities for trainees and faculty from groups underrepresented in medicine. In addition to research expertise on the effects of cannabis on neurocognition and health across the lifespan, the Division's research programs also include basic science (i.e. genetics, epigenetics), human laboratory studies, medication and behavioral treatment development, deep brain stimulation, and clinical trials research, including affiliation with the NIAAA and NIDA Clinical Trials Networks.
The Division of Addiction Science, Prevention & Treatment is nationally recognized as one of the premier addiction research and clinical training sites.
Current clinical care modalities (adults):